Skip to main content
Article thumbnail
Location of Repository

Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa)

By Abdelali Agouni, Anne-Hélène Lagrue-Lak-Hal, Hadj Ahmed Mostefai, Angela Tesse, Paul Mulder, Philippe Rouet, Franck Desmoulin, Christophe Heymes, Maria Carmen Martínez and Ramaroson Andriantsitohaina

Abstract

Peer reviewedPublisher PD

Topics: animals, blood glucose, blood pressure, blotting, western, echocardiography, electron spin resonance spectroscopy, enzyme activation, flavonoids, fructosamine, lipid metabolism, lipids, mesenteric arteries, NADPH oxidase, nitric oxide, nitric oxide synthase type III, obesity, phenols, rats, rats, Zucker, superoxides, wine, R Medicine, R
Year: 2009
DOI identifier: 10.1371/journal.pone.0005557
OAI identifier: oai:aura.abdn.ac.uk:2164/770
Journal:

Suggested articles

Citations

  1. (2005). A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats.
  2. (2003). Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats. doi
  3. (2006). Beneficial effects of Provinols: cardiovascular system and kidney.
  4. (2006). Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. doi
  5. (1997). Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. doi
  6. (2008). Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke.
  7. (1998). Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo.
  8. (2007). Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. doi
  9. (2005). Endothelial function: cardiac events. doi
  10. (1998). Flavonoids: a class of modulators with bifunctional interactions at vicinal ATPand steroid-binding sites on mouse P-glycoprotein. doi
  11. (2009). Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. doi
  12. (1972). Insulin and obesity in the Zucker genetically obese rat ‘‘fatty’’. doi
  13. (2006). Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. doi
  14. (2004). Insulin resistance and the endothelium. doi
  15. (1991). Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. doi
  16. (2006). Is insulin resistance atherogenic? Possible mechanisms. doi
  17. (1996). Leptin receptor missense mutation in the fatty Zucker rat. doi
  18. (2009). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. doi
  19. (2005). Metabolic syndrome and endothelial dysfunction. doi
  20. (2001). Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
  21. (1997). Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. doi
  22. (2000). Obesity as a medical problem. doi
  23. (1996). Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. doi
  24. (1995). Pathophysiology of insulin resistance in human disease. doi
  25. (1996). Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. doi
  26. (1999). Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. doi
  27. (2005). Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. doi
  28. (2003). Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. doi
  29. (2004). Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. doi
  30. (2006). Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. doi
  31. (2004). Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. doi
  32. (2001). Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. doi
  33. (2006). Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. doi
  34. (1986). Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. doi
  35. (2007). Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. doi
  36. (2008). The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis. doi
  37. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.
  38. (2000). The perils of portliness: causes and consequences of visceral adiposity. doi
  39. (1989). The Zucker fatty rat as a genetic model of obesity and hypertension. doi
  40. (2006). Vascular effects of red wine polyphenols in chronic stress-exposed Wistar-Kyoto rats. doi
  41. (2001). Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. doi
  42. (2002). Wine polyphenols improve cardiovascular remodeling and vascular function in NOdeficient hypertension. doi
  43. (2004). Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.